[MOL] Drug Therapy-Series [02824] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Drug Therapy-Series



ondansetron 

Tradename Zofran 
Manufacturer Glaxo 
Treatment Class Psychopharmacologic and Neurologic (CNS) 
Indication Chemotherapy-induced vomiting 
MSB Review: Granisetron Approved for Chemotherapy-induced Vomiting 
MSB Review: Oral Ondansetron Indication Expanded to Post-Op Nausea and
Vomiting 
MSB Review: Dolasetron for Chemotherapy-induced Nausea 
PNN Review Droperidol Similar to Ondansetron for PONV 

oprelvekin 

Tradename Neumega 
Manufacturer Genetics Institute 
Treatment Class Cardiovascular 
Indication Prevention of severe thrombocytopenia and the reduction of the
need for platelet transfusion following myelosuppressive chemotherapy 
MSB Review: Oprelvekin for Prevention of Severe Thrombocytopenia 

paclitaxel 

Tradename Taxol 
Manufacturer Bristol-Myers Squibb 
Treatment Class Oncology 
Indication Breast, Ovarian Cancer 
Graphic Chemical structure 
DrugPR: NEW TAXOL REGIMEN SIGNIFICANTLY INCREASES A WOMAN'S CHANCES FOR
BREAST CANCER CURE 
MSB Review Semisynthetic Taxol Approved for Breast, Ovarian Cancer 
MSB Review Paclitaxel Plus Carboplatin Shows Promise in Advanced NSCLC 
MSB Review: Topotecan Approved for Ovarian Cancer 
PNN Review Breast Cancer Symposium Opens in San Antonio 

pegaspargase 

Tradename Oncaspar 
Manufacturer Rhone-Poulenc Rorer 
Treatment Class Oncology 
Indication Acute Lymphoblastic Leukemia 
MSB Review Pegasparagase Approved for Acute Lymphoblastic Leukemia

pilocarpine hydrochloride 

Tradename Salagen 
Manufacturer MGI Pharma 
Treatment Class Oncology 
Indication Radiation-induced dry mouth (xerostomia) 
MSB Review Oral Pilocarpine Hydrochloride for Radiation-induced Dry Mouth 

porfimer sodium 

Tradename Photofrin 
Manufacturer Sanofi 
Treatment Class Oncology 
Indication esophageal cancer; Palliative management of advanced esophageal
cancer and microinvasive endobronchial nonsmall cell lung cancer in
patients for whom surgery or radiotherapy is not an option 
MSB Review Photofrin Recommended as Palliative for Esophageal Cancer 
MSB Review: Porfimer Approved for Esophageal Cancer Obstructions 
MSB Review: Porfimer: A Novel Approach to the Management of in situ Cancers

PNN: Light-Activated Porfimer Approved for Lung Cancer 

vinorelbine tartrate 

Manufacturer Burroughs Wellcome 
Tradename Navelbine 
Treatment Class Oncology 
Indication Non-small-cell Lung Cancer 
MSB Review: Vinorelbine Recommended for Non-Small-Cell Lung Cancer 
MSB Review: Vinorelbine Approved for Advanced Lung Cancer 
DrugPR: TAXOTERE(R)/NAVELBINE(R) COMBINATION THERAPY DEMONSTRATES PROMISING
ACTIVITY IN ADVANCED BREAST CANCER 


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------